Inventor

GRINBERG ASYA

US66 patents

⚠️ This page may combine multiple inventors who share the name “GRINBERG ASYA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GRINBERG ASYA

ACCELERON PHARMA INC

Transforming growth factor beta receptor II fusion polypeptides

ALK7:actriib heteromultimers and uses thereof

ALK4:ActRIIB heteromultimers and uses thereof

Single arm type I and type II receptor fusion proteins and uses thereof

Activin type 2 receptor antibodies

TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof

Follistatin-related fusion proteins

ALK4:ActRIIB heteromultimers and uses thereof

TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof

Methods for treatment of charcot-marie-tooth disease with follistatin polypeptides

ALK7:ActRIIB heteromultimers and uses thereof

ALK4:ActRIIB heteromultimers and uses thereof

Methods for treatment of amyotrophic lateral sclerosis with follistatin fusion proteins

Follistatin-related fusion proteins

ALK7 binding proteins and uses thereof

ALK7 binding proteins and uses thereof

Transforming growth factor-beta receptor type II fusion polypeptides

Polynucleotides encoding an actriib antibody

Methods for treatment of Duchenne muscular dystrophy with follistatin polypeptides

Methods and compositions for treatment of disorders with follistatin polypeptides

Uses of cerberus, coco and derivatives thereof

ActRII-binding proteins and uses thereof

TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof

ALK4:actriib heteromultimers and uses thereof

ALK1 receptor and ligand antagonists and uses thereof

Methods of treatment of muscular dystrophy with ALK4:ActRIIB heteromultimers

Activin type 2 receptor binding proteins methods of making them

ALK7 antagonists and uses thereof

ALK7:ActRIIB heteromultimers and uses thereof

ALK7 binding proteins and uses thereof

TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof

Single-arm type I and type II receptor fusion proteins and uses thereof

Methods of treating a fibrotic disorder by administering transforming growth factor beta receptor II fusion polypeptides

Method for treating a muscle-related disorder with follistatin-related fusion proteins

Methods of increasing muscle mass by administration of activin type 2 receptor antibodies

DRAGONFLY THERAPEUTICS INC

Antibody variable domains targeting the NKG2D receptor

Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-associated antigen for activation of natural killer cells and therapeutic uses thereof to treat cancer

Antibody variable domains targeting the NKG2D receptor

Heterodimeric Fc-fused proteins

Cancer therapy involving an anti-PD1 antibody and a multi-specific binding protein that binds NKG2D, CD16, and a tumor-associated antigen

Antibody variable domains targeting the NKG2D receptor

Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of use

GRINBERG ASYA

ALK1 receptor and ligand antagonist and uses thereof

Pharmaceutical preparations comprising an ALK1-Fc fusion protein

Compositions comprising ALK1-ECD protein

Endoglin polypeptides and uses thereof

BRIGHAM & WOMENS HOSPITAL INC

Methods for treating pulmonary hypertension with a TGF-beta type II receptor-FC fusion protein

Methods for treating pulmonary hypertension with a ligand binding domain of a TGF-beta type II receptor

KUMAR RAVINDRA

Method of detection of neutralizing anti-actriib antibodies

SEEHRA JASBIR

Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof